Chemoradiatie bij het spierinvasieve blaascarcinoom

Translated title of the contribution: Chemoradiation for muscle invasive bladder cancer

Richard P. Meijer*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review


The combination of varying treatment strategies (e.g. neoadjuvant chemotherapy and surgery or radiotherapy) in a multimodal setting are increasingly being used in various tumour types. For patients with muscle invasive bladder cancer, multimodal therapy consisting of transurethral resection followed by chemoradiation offers a bladder preserving treatment option. This treatment will result in good long term recurrence free survival, acceptable bladder function, and minimal gastro-intestinal toxicity. Nevertheless, a strict follow-up schedule with imaging and cystoscopy is required in order to detect local recurrence in time for salvage treatment.

Translated title of the contributionChemoradiation for muscle invasive bladder cancer
Original languageDutch
Pages (from-to)210-214
Number of pages5
JournalTijdschrift voor Urologie
Issue number8
Publication statusPublished - 1 Dec 2015


  • bladder cancer
  • chemoradiation
  • multimodal therapy


Dive into the research topics of 'Chemoradiation for muscle invasive bladder cancer'. Together they form a unique fingerprint.

Cite this